In a paper published online in Cancer Cell, scientists at the University of California, San Diego School of Medicine describe a novel mouse model that closely resembles human NASH and use it to demonstrate that interference with a key inflammatory protein inhibits both the development of NASH and its progression to liver cancer.
In a paper published online this week in Nature, researchers at the University of California, San Diego School of Medicine elaborate upon a crucial signaling pathway and the role of key proteins, which may help clear the way to generate HSCs from human pluripotent precursors, similar to advances with other kinds of tissue stem cells.
Oncologists at UC San Diego Moores Cancer Center are the first in San Diego to meld MRI technology with a traditional ultrasound prostate exam to create a three-dimensional map of the prostate that allows physicians to view growths that were previously undetectable.
Benefunder, a San Diego-based philanthropic research funding platform for higher education institutions, and the University of California, San Diego, recognized as one of the top 15 research universities worldwide, have signed a Memorandum of Understanding (MOU) to embark on a two-year pilot program. The long-term goal of the partnership between UC San Diego and Benefunder is to allow junior and senior faculty in diverse disciplines to create funding relationships with private supporters from across the country, and generate one-time and recurring donations to fund their work and vision.
A recent study conducted by researchers at the University of California, San Diego School of Medicine and the University of Hawaii demonstrates a new approach to measuring early brain development of infants, resulting in more accurate whole brain growth charts and providing the first estimates for growth trajectories of subcortical areas during the first three months after birth.
Researchers at the University of California, San Diego School of Medicine have launched a clinical trial to investigate the safety of neural stem cell transplantation in patients with chronic spinal cord injuries. This Phase I clinical trial is recruiting eight patients for the 5-year study.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
